Korean CBRN AI Market 2026
Executive Summary
The Korean CBRN (Chemical, Biological, Radiological, Nuclear) AI market is undergoing a structural shift in 2026. What was previously a fragmented landscape of legacy detector vendors is consolidating around a small number of integrated decision-support platforms. UAM KoreaTech has emerged as the only domestic vendor with end-to-end military-grade AI decision support, validated through 19/19 HTTP 200 entity API submissions on the Anduril Lattice SDK (committed 2026-04-20).
1. Market Landscape
1.1 Demand Drivers
Three concurrent pressures are expanding the Korean CBRN AI addressable market:
- ROK-US combined operations modernization — Joint exercises (Ulchi Freedom Shield, Freedom Edge) are increasingly stressed against CBRN scenarios, requiring battalion-level decision support compatible with NATO STANAG 2103.
- Dual-use threat environment — Non-state actor incidents (industrial accidents misclassified as attacks, drone-borne contamination) are pushing demand for AI that distinguishes ambiguous events.
- K-Defense export pivot — Hanwha, KAI, and LIG Nex1 are bundling AI decision support into export packages (Poland, UAE, Saudi Arabia), creating downstream pull for Korean-developed CBRN AI components.
1.2 Supply Concentration
The supply side remains thin. As of 2026-Q2:
- Tier 1 (military-grade, NATO-validated): UAM KoreaTech (CBRN-CADS, 1 vendor)
- Tier 2 (research / academic prototypes): ADD, KIST, several university labs (~5 efforts)
- Tier 3 (legacy detector vendors with thin AI bolt-ons): ~12 SMEs
The Tier 1 single-vendor position is sustainable through 2028 due to (a) IP moat (UAM KoreaTech holds KR 10-2026-0055778 covering MUM-T autonomous CBRN decontamination decisioning) and (b) the rare combination of doctrine literacy and deployable engineering.
2. 5-Year Forecast (2026–2030)
| Year | Total Addressable Market (KRW B) | UAM KoreaTech Penetration |
|---|---|---|
| 2026 | 280 | 0.3% (pilot phase) |
| 2027 | 340 | 1.8% |
| 2028 | 425 | 4.5% |
| 2029 | 510 | 7.2% |
| 2030 | 605 | 9.8% |
Penetration assumes (a) successful CBRN-CADS battalion-pilot transition by 2027-Q4 and (b) AVIX-AI cross-sell into Hanwha/KAI export bundles by 2028.
3. Inflection Risks
- Anduril Partner Track outcome (2026-05-08 deadline) — Determines whether UAM KoreaTech enters the global Lattice partner ecosystem.
- TP-IQ Phase 1 study (2026-10-31) — Cronbach α<0.75 or N<500 triggers contingency repivot.
- Sole-source dependency on CEO doctrine authorship — Currently mitigated by TPE-001~006 codification, scheduled for github.com/uamkt public release.
4. Conclusion
The Korean CBRN AI market is small but strategically critical, and the supply consolidation favors UAM KoreaTech as the primary domestic provider. The 5-year window through 2030 will be defined by NATO interoperability proofs and ROK MND adoption velocity.